<?xml version="1.0" encoding="UTF-8"?>
<ReportSnapshot Major="1" Minor="0" Revision="1">
	<CoIDs>
		<CoID Type="RepNo">EF944</CoID>
		<CoID Type="CompanyName">Allied Minds PLC</CoID>
	</CoIDs>
	<Issues>
		<Issue ID="1" Type="C" Desc="Common Stock" Order="1">
			<IssueID Type="Name">Ordinary Shares</IssueID>
			<IssueID Type="Ticker">ALM</IssueID>
			<IssueID Type="CUSIP">G0210L102</IssueID>
			<IssueID Type="ISIN">GB00BLRLH124</IssueID>
			<IssueID Type="RIC">ALML.L</IssueID>
			<IssueID Type="SEDOL">BLRLH12</IssueID>
			<IssueID Type="DisplayRIC">ALML.L</IssueID>
			<IssueID Type="InstrumentPI">159076338</IssueID>
			<IssueID Type="QuotePI">159283731</IssueID>
			<Exchange Code="LON" Country="GBR">London Stock Exchange (LON)</Exchange>
		</Issue>
	</Issues>
	<CoGeneralInfo>
		<CoStatus Code="1">Active</CoStatus>
		<CoType Code="EQU">Equity Issue</CoType>
		<LastModified>2015-12-04</LastModified>
		<LatestAvailableAnnual>2014-12-31</LatestAvailableAnnual>
		<LatestAvailableInterim>2015-06-30</LatestAvailableInterim>
		<Employees LastUpdated="2014-12-31">298</Employees>
		<SharesOut Date="2015-11-03" TotalFloat="184875567.0">215637363.0</SharesOut>
		<ReportingCurrency Code="USD">U.S. Dollars</ReportingCurrency>
		<MostRecentExchange Date="2016-02-22">1.0</MostRecentExchange>
	</CoGeneralInfo>
	<TextInfo>
		<Text Type="Business Summary" lastModified="2015-09-29T04:38:16">Allied Minds plc is a diversified holding company. The Company is a science and technology development and commercialization company. The Company is engaged in forming, funding, managing and building start-up companies, which undertake research and product development to commercialize the scientific research. Its segments include Early stage companies, including subsidiary businesses that are in the early-stage of their lifecycle characterized by incubation, research and development activities, and Commercial stage companies, including subsidiary businesses that have completed their research and development activities and that have developed one or more products that are marketed. It has 22 subsidiary businesses across the life sciences and technology sectors in medical devices, biologics, pharmaceutical compounds, cyber security, wireless communications, semiconductors, medical diagnostics and food safety.</Text>
		<Text Type="Financial Summary" lastModified="2015-08-27T07:22:10">BRIEF: For the six months ended 30 June 2015, Allied Minds PLC revenues decreased 49% to $1.5M. Net loss increased 39% to $30.4M. Revenues reflect Commercial - RFB segment decrease of 79% to $464K, Commercial - Other segment decrease of 12% to $411K. Higher net loss reflects Research and development expenses increase from $9.7M to $19.7M (expense), Selling, general and administrative expe increase of 12% to $20.7M (expense).</Text>
	</TextInfo>
	<contactInfo lastUpdated="2016-01-17T23:39:25">
		<streetAddress line="1">40 Duke Place</streetAddress>
		<streetAddress line="2"></streetAddress>
		<streetAddress line="3"></streetAddress>
		<city>LONDON</city>
		<state-region></state-region>
		<postalCode>EC3A 7NH</postalCode>
		<country code="GBR">United Kingdom</country>
		<contactName>Svetoslav Milenkov</contactName>
		<contactTitle>Director - Finance</contactTitle>
		<phone></phone>
	</contactInfo>
	<webLinks lastUpdated="2015-12-04T10:00:07"><webSite mainCategory="Home Page">http://www.alliedminds.com/</webSite><eMail mainCategory="Company Contact/E-mail">sam@alliedminds.com</eMail></webLinks>
	<peerInfo lastUpdated="2016-01-17T23:39:25">
		<IndustryInfo>
			<Industry type="TRBC" order="1" reported="0" code="5510202010" mnem="">Investment Management &amp; Fund Operators - NEC</Industry>
			<Industry type="NAICS" order="1" reported="0" code="52599" mnem="">Other Financial Vehicles</Industry>
			<Industry type="NAICS" order="2" reported="0" code="54171" mnem="">Research and Development in the Physical, Engineering, and Life Sciences</Industry>
			<Industry type="SIC" order="1" reported="0" code="6726" mnem="">Investment Offices, Nec</Industry>
			<Industry type="SIC" order="2" reported="0" code="8731" mnem="">Commercial Physical Research</Industry>
		</IndustryInfo>
	</peerInfo>
	<officers>
		<officer rank="1" since="NA">
			<firstName>Christopher</firstName>
			<mI>Andrew</mI>
			<lastName>Silva</lastName>
			<age>52 </age>
			<title startYear="NA" startMonth="" startDay="" iD1="CEO" abbr1="CEO" iD2="DRC" abbr2="Dir.">Chief Executive Officer, Director</title>
		</officer>
		<officer rank="2" since="09/01/2015">
			<firstName>Joseph</firstName>
			<mI></mI>
			<lastName>Pignato</lastName>
			<age></age>
			<title startYear="2015" startMonth="09" startDay="01" iD1="CFO" abbr1="CFO" iD2="DRC" abbr2="Dir.">Chief Financial Officer, Director</title>
		</officer>
		<officer rank="3" since="NA">
			<firstName>Michael</firstName>
			<mI>Scott</mI>
			<lastName>Turner</lastName>
			<age>47 </age>
			<title startYear="NA" startMonth="" startDay="" iD1="GCN" abbr1="Counsel" iD2="SEC" abbr2="Secy.">General Counsel, Secretary</title>
		</officer>
	</officers>
	<Ratios PriceCurrency="GBP" ReportingCurrency="USD" ExchangeRate="0.70681" LatestAvailableDate="2014-12-31">
		<Group ID="Price and Volume">
			<Ratio FieldName="NPRICE" Type="N">3.29700</Ratio>
			<Ratio FieldName="NHIG" Type="N">7.29000</Ratio>
			<Ratio FieldName="NLOW" Type="N">2.39000</Ratio>
			<Ratio FieldName="PDATE" Type="D">2016-02-23T00:00:00</Ratio>
			<Ratio FieldName="VOL10DAVG" Type="N">0.17765</Ratio>
			<Ratio FieldName="EV" Type="N">541.78355</Ratio>
		</Group>
		<Group ID="Income Statement">
			<Ratio FieldName="MKTCAP" Type="N">710.95640</Ratio>
			<Ratio FieldName="AREV" Type="N">5.45304</Ratio>
			<Ratio FieldName="AEBITD" Type="N">-38.90000</Ratio>
			<Ratio FieldName="ANIAC" Type="N">-32.14431</Ratio>
		</Group>
		<Group ID="Per share data">
			<Ratio FieldName="AEPSXCLXOR" Type="N">-0.17245</Ratio>
			<Ratio FieldName="AREVPS" Type="N">0.02926</Ratio>
			<Ratio FieldName="ABVPS" Type="N">0.81709</Ratio>
			<Ratio FieldName="ACSHPS" Type="N">0.79070</Ratio>
			<Ratio FieldName="ACFSHR" Type="N">-0.20786</Ratio>
			<Ratio FieldName="ADIVSHR" Type="N">0.00000</Ratio>
		</Group>
		<Group ID="Other Ratios">
			<Ratio FieldName="AGROSMGN" Type="N">29.79909</Ratio>
			<Ratio FieldName="AROEPCT" Type="N">-24.90881</Ratio>
			<Ratio FieldName="APR2REV" Type="N">130.37800</Ratio>
			<Ratio FieldName="APEEXCLXOR" Type="N">-99999.99000</Ratio>
			<Ratio FieldName="APRICE2BK" Type="N">4.03507</Ratio>
			<Ratio FieldName="Employees" Type="N">298</Ratio>
		</Group>
	</Ratios>
	<ForecastData ConsensusType="Mean" CurFiscalYear="2015" CurFiscalYearEndMonth="12" CurInterimEndCalYear="2015" CurInterimEndMonth="9" EarningsBasis="PRX">
		<Ratio FieldName="ConsRecom" Type="N">
			<Value PeriodType="CURR">1</Value>
		</Ratio>
		<Ratio FieldName="TargetPrice" Type="N">
			<Value PeriodType="CURR">6.36000</Value>
		</Ratio>
		<Ratio FieldName="ProjLTGrowthRate" Type="N">
			<Value PeriodType="CURR">-99999.99000</Value>
		</Ratio>
		<Ratio FieldName="ProjPE" Type="N">
			<Value PeriodType="CURR">-18.43960</Value>
		</Ratio>
		<Ratio FieldName="ProjSales" Type="N">
			<Value PeriodType="CURR">4.12970</Value>
		</Ratio>
		<Ratio FieldName="ProjSalesQ" Type="N">
			<Value PeriodType="CURR">-99999.99000</Value>
		</Ratio>
		<Ratio FieldName="ProjEPS" Type="N">
			<Value PeriodType="CURR">-0.17880</Value>
		</Ratio>
		<Ratio FieldName="ProjEPSQ" Type="N">
			<Value PeriodType="CURR">-99999.99000</Value>
		</Ratio>
		<Ratio FieldName="ProjProfit" Type="N">
			<Value PeriodType="CURR">-48.81130</Value>
		</Ratio>
		<Ratio FieldName="ProjDPS" Type="N">
			<Value PeriodType="CURR">-99999.99000</Value>
		</Ratio>
	</ForecastData>
</ReportSnapshot>
